1 丰有吉,沈铿.妇产科学.第2版.北京:人民卫生出版社,2010:296-331. 2 李蕾,邹先彪.解读2012年欧洲尖锐湿疣治疗指南.实用皮肤病学杂志,2012,5:344-366. 3 范余娟,蒙亚晴,罗雪慧,等.女性外阴尖锐湿疣HPV感染类型及其与临床复发关系研究.中国计划生育和妇产科,2011,3:14-17. 4 熊承良,刘继红,廖爱华.生殖疾病学.福州:福建科学技术出版社,2007:180-192. 5 汤雅琴,张霞,阮建波,等.慢性宫颈炎患者人乳头瘤病毒基因型检测及分析.齐齐哈尔医学院学报,2012,33:5-7. 6 伍萍.外阴上皮内瘤变与HPV感染型别相关性临床研究.中国医药导报,2012,9:44-48. 7 Srodon M,Stoler MH,Baber GB,et al.The distribution of low and high-risk HPV types in vulvar and vaginal intraepithelial neoplasia (VIN and VaIN).Am J Surg Pathol,2006,30:1513-1518. 8 谷鸿喜,陈锦英.医学微生物学.第2版.北京:北京大学医学出版社,2009:306-308. 9 王言奎,罗兵,王云,等.子宫内膜癌组织中人乳头状瘤病毒16、18型的检测.中华妇产科杂志,1999,34:746-747. 10 张英姿,韩玉贞,高勇,等.人乳头状瘤病毒在子宫内膜癌组织中的检测.中国基层医药,2009,16:1757-1758. 11 姚远洋,赵昀,鲍冬梅,等.子宫内膜组织人乳头瘤病毒感染的初步研究.中国妇产科临床杂志,2008,9:97-99. 12 Moody CA,Laimins LA.Human papillomaviruses activate the ATM DNA damage pathway for viral genome amplification upon differentiation.PLoS Pathog,2009,5:e1000605. 13 Klingelhutz AJ,Roman A.Cellular transformation by human papillomaviruses:lessons learned by comparing high- and low-risk viruses.Virology,2012,424:77-98. 14 James MA,Lee JH,Klingelhutz AJ.HPV16-E6 associated hTERT promoter acetylation is E6AP dependent,increased in later passage cells and enhanced by loss of p300.Int J Cancer,2006,119:1878-1885. 15 McLaughlin-Drubin ME,Crum CP,M nger K.Human papillomavirus E7 oncoprotein induces KDM6A and KDM6B histone demethylase expression and causes epigenetic reprogramming.Proc Natl Acad Sci U S A,2011,108:2130-2135. 16 Melar-New M,Laimins LA.Human papillomaviruses modulate expression of microRNA 203 upon epithelial differentiation to control levels of p63 proteins.J Virol,2006,84:5212-5221. 17 Moody CA,Laimins LA.Human papillomavirus oncoproteins:pathways to transformation.Nat Rev Cancer,2010,10:550-560. 18 Krishna Subbaiah V,Massimi P,Boon SS,et al.The invasive capacity of HPV transformed cells requires the hDlg-dependent enhancement of SGEF/RhoG activity.PLoS Pathog,2012,8:e1002543. 19 White EA,Sowa ME,Tan MJ,et al.Systematic identification of interactions between host cell proteins and E7 oncoproteins from diverse human papillomaviruses.Proc Natl Acad Sci U S A,2012,109:E260-267. 20 Zhou X,M nger K.Expression of the human papillomavirus type 16 E7 oncoprotein induces an autophagy-related process and sensitizes normal human keratinocytes to cell death in response to growth factor deprivation.Virology,2009,385:192-197. 21 Zwerschke W,Mazurek S,Massimi P,et al.Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein.Proc Natl Acad Sci U S A,1999,96:1291-1296. 22 Spangle JM,M nger K.The human papillomavirus type 16 E6 oncoprotein activates mTORC1 signaling and increases protein synthesis.J Virol,2010,84:9398-9407. 23 郎景和.迎接子宫颈癌预防的全球挑战与机遇.中华妇产科杂志,2002,37:129-131. 24 李婷,刘凤英,徐晓明,等.Survivin与高危型人乳头瘤病毒在宫颈癌及癌前病变中的表达和意义.实用妇产科杂志,2005,21:106-109. 25 王会娟,刘欣,王丽.Survivin、Ki67和P63在宫颈上皮内瘤变及宫颈癌中的表达及临床意义.青岛医药卫生,2013,45:11-14. 26 齐朝阳,陈艳,曾鸿,等.宫颈上皮内肿瘤P16、P53、Ki67、P63的表达与HPV感染及其临床意义.实用医学杂志,2011,27:3638-3640. 27 叶霞,王丽宏,陈玲.宫颈癌发病中HPV病毒蛋白和P53蛋白表达的变化及临床意义.山西医药杂志,2008,37:1041-1042. 28 张建兰,柳晓春,秦艳,等.宫颈液基细胞P16、Ki-67诊断非典型鳞状细胞的价值.国际生殖健康/计划生育杂志,2010,29:256-280. 29 任秀苗.人类乳头状瘤病毒E6蛋白及人类端粒酶反转录酶在子宫颈癌组织中的表达及其意义.肿瘤研究与临床,2012,24:274-276.